The department is a lively community that is recognised internationally as one of the top centres for research and teaching in development studies.
Rethinking domestic and international finance for HIV
Antiretroviral drugs are now available in developing countries at a moderate cost. People living with HIV can live almost normal lives if provided with and adhering to treatment. HIV has shifted from a medical issue to a financial issue: in poor and high-prevalence countries, commitments to increase access to antiretroviral treatment create a huge fiscal liability. In this research, I study how domestic and international financing can be used to meet this liability.